ANI Pharmaceuticals | ANIP - Debt

Stock Price
76.82
Daily Change
0.12 0.16%
Monthly
-5.55%
Yearly
39.65%
Q1 Forecast
75.36

ANI Pharmaceuticals reported $620.31M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
AbbVie USD 1000K 70.48B Sep/2025
ANI Pharmaceuticals USD 620.31M 1.25M Sep/2025
Assertio Holdings USD 38.87M 615K Sep/2023
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Emergent BioSolutions USD 903.2M 495.2M Jun/2023
Heron Therapeutics USD 149.65M 157K Sep/2024
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Knight Therapeutics CAD 106.24M 1.5M Sep/2025
Nektar Therapeutics USD 0 0 Jun/2022
Novartis USD 32.02B 615M Sep/2025
Omeros USD 442.16M 199K Sep/2023
Perrigo USD 3.65B 454.7M Jun/2025
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025